Related references
Note: Only part of the references are listed.Hairy cell leukemia 2022: Update on diagnosis, risk-stratification, and treatment
Xavier Troussard et al.
AMERICAN JOURNAL OF HEMATOLOGY (2022)
A 3-decade multicenter European experience with cladribine as upfront treatment in 384 patients with hairy cell leukemia
Alessandro Broccoli et al.
BLOOD ADVANCES (2022)
Long-term follow-up of cladribine treatment in hairy cell leukemia: 30-year experience in a multicentric Italian study
Livio Pagano et al.
BLOOD CANCER JOURNAL (2022)
The treatment of hairy cell leukemia with a focus on long lasting responses to cladribine: A 30-year experience
Alessandro Broccoli et al.
AMERICAN JOURNAL OF HEMATOLOGY (2021)
Randomized Phase II Study of First-Line Cladribine With Concurrent or Delayed Rituximab in Patients With Hairy Cell Leukemia
Dai Chihara et al.
JOURNAL OF CLINICAL ONCOLOGY (2020)
Analysis of a cohort of 279 patients with hairy-cell leukemia (HCL): 10 years of follow-up
Jerome Paillassa et al.
BLOOD CANCER JOURNAL (2020)
Prospective long-term follow-up after first-line subcutaneous cladribine in hairy cell leukemia: a SAKK trial
Rudolf Benz et al.
BLOOD ADVANCES (2020)
Hairy cell leukemia: 2020 update on diagnosis, risk stratification, and treatment
Elsa Maitre et al.
AMERICAN JOURNAL OF HEMATOLOGY (2019)
Hairy Cell Leukemia: Retrospective Analysis of Demographic Data and Outcome of 203 Patients from 12 Medical Centers in Israel
Michal Inbar et al.
ANTICANCER RESEARCH (2018)
Long-term durable remission by cladribine followed by rituximab in patients with hairy cell leukaemia: update of a phase II trial
Dai Chihara et al.
BRITISH JOURNAL OF HAEMATOLOGY (2016)
Long-term follow-up after purine analogue therapy in hairy cell leukaemia
Monica Else et al.
BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY (2015)
Clinical features and diagnosis of hairy cell leukemia
Graeme R. Quest et al.
BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY (2015)
Long-term follow-up and second malignancies in 487 patients with hairy cell leukaemia
Edouard Cornet et al.
BRITISH JOURNAL OF HAEMATOLOGY (2014)
Update on the Biology and Treatment Options for Hairy Cell Leukemia
Preetesh Jain et al.
CURRENT TREATMENT OPTIONS IN ONCOLOGY (2014)
Rituximab with pentostatin or cladribine: an effective combination treatment for hairy cell leukemia after disease recurrence
Monica Else et al.
LEUKEMIA & LYMPHOMA (2011)
Long-term results for pentostatin and cladribine treatment of hairy cell leukemia
Claire E. Dearden et al.
LEUKEMIA & LYMPHOMA (2011)
Chemo-immunotherapy for hairy cell leukemia
Farhad Ravandi
LEUKEMIA & LYMPHOMA (2011)
Long-term follow-up of 233 patients with hairy cell leukaemia, treated initially with pentostatin or cladribine, at a median of 16 years from diagnosis
Monica Else et al.
BRITISH JOURNAL OF HAEMATOLOGY (2009)
The role of rituximab in combination with pentostatin or cladribine for the treatment of recurrent/refractory hairy cell leukemia
Monica Else et al.
CANCER (2007)
Lymphorna incidence patterns by WHO subtype in the United States, 1992-2001
LM Morton et al.
BLOOD (2006)
Long remissions in hairy cell leukemia with purine analogs - A report of 219 patients with a median follow-up of 12.5 years
M Else et al.
CANCER (2005)
Share Paper
